研究者学術情報データベース

カクモト　ミキオ
角本　幹夫
KAKUMOTO Mikio

所属薬学部薬学科

職名教授

論文
1.	2022/09	Decreased serum copper concentrations by zinc administration in preterm infants with hypozincemia are associated with a lower postmenstrual age: A single-center retrospective observational study │ Yakugaku Zasshi │ 142,999-1004頁 (共著)
2.	2022	臨床準備教育における治療薬物モニタリング（TDM）実習でのファーマコゲノミクス演習の教育効果 │ 薬学教育 │ (共著)
3.	2021/11/12	立命館大学薬学部における海外留学―Toronto Clinical Training Program―の取り組み │ 薬学教育 │ 5 (1) (共著)
4.	2021/03	Effects of antiepileptic drugs' administration during pregnancy on the nerve cell proliferation and axonal outgrowth of human neuroblastoma SH-SY5Y nerve cells. │ Biochem Biophys Res Commun, │ 554,151-157頁 (共著)
5.	2021	Administration of zinc to preterm infants with hypozincemia does not reduce serum copper concentrations in most cases: a single-center retrospective observational study │ J Pharm Health Care Sci. │ 7 (共著)
6.	2021	Incorrect Holding Angle of Dry Powder Inhaler during the Drug-Loading Step Significantly Decreases Output Efficiency. │ Biol Pharm Bull, │ 44 (6),822-829頁 (共著)
7.	2021	Pharmacokinetics of intravitreal vancomycin and ceftazidime in silicone oil-filled macaque eyes. │ Transl Vis Sci Technol, │ 10 (1) (共著)
8.	2020	Is “slow inhalation” always suitable for pressurized metered dose inhaler? │ AAPS PharmSciTech │ 21 (53) (共著)
9.	2020	アブラキサン再溶解時間に対する側孔型プラスチック製注射針の有用性に関する検討. │ 医療薬学 │ 46 (7),367-372頁 (共著)
10.	2019/04	学生の臨床意識向上を目指した実務実習事前学習における治療薬物モニタリング（TDM）教育 │ 薬学教育 │ 3 (共著)
11.	2019	タクロリムスとボノプラザン併用により血中タクロリムス濃度が著明に上昇した1症例 │ 日本病院薬剤師会雑誌 │ 55 (11),1291 (共著)
12.	2019	効果的なエアロゾル吸入療法を実現するための吸入支援 │ 日本耳鼻咽喉科感染症・エアロゾル学会会誌 │ 7 (2),51-54頁 (共著)
13.	2019	実務実習事前学習における効果的な呼吸器機能評価実習の取り組み │ 薬学教育 │ 3 (共著)
14.	2018/07	Pharmaceutical stability of colloidal saccharated iron oxide injection in normal saline. │ J Pharm Health Care Sci. │ 4,21 (共著)
15.	2018	効果的なフィジカルアセスメント学習の工夫 ~血圧・脈拍測定における運動負荷の導入 │ 薬学教育 │ 2 (共著)
16.	2011	パクリタキセル・カルボプラチン併用療法とワルファリンとの薬物相互作用に関する調査　―抗凝固効果への影響― │ 医療薬学 │ 37 (8),443-448 (共著)
17.	2010	ACMIA法で異常高値を示す症例の判別法の検討 │ TDM研究 │ 27 (4),168-172 (共著)
18.	2010	Fractional absorption of active absorbable algal calcium (AAACa) and calcium carbonate measured by a dual stable-isotope method. │ Nutrients │ 2 (7),752-761 (共著)
19.	2009	Effect of α-adrenoceptor antagonist doxazosin on MDR1-mediated multidrug resistance and transcellular transport. │ Oncol. Res. │ 17,527-533 (共著)
20.	2007	Change in pharmacokinetics of model compounds with different elimination processes in rats during hypothermia. │ Biol. Pharm. Bull. │ 30,1763-1767 (共著)
21.	2006	Effect of therapeutic moderate hypothermia on multi-drug resistance protein 1-mediated transepithelial transport of drugs. │ Neurol. Med. Chir. │ 46,321-327 (共著)
22.	2006	Effects of acid and lactone forms of eight HMG-CoA reductase inhibitors on CYP-mediated metabolism and MDR1-mediated transport. │ Pharm. Res. │ 23,506-512 (共著)
23.	2006	Haloperidol is an inhibitor but not substrate for MDR1/P-glycoprotein. │ J. Pharm. Pharmacol. │ 58,1617-1622 (共著)
24.	2006	Intravenous infusion of an antisense oligonucleotide results in exon skipping in muscle dystrophin mRNA of Duchenne muscular dystrophy. │ Pediatr. Res. │ 59,690-694 (共著)
25.	2005	Effect of micafungin on cytochrome P450 3A4 and multidrug resistance protein 1 activities, and its comparison with azole antifungal drugs. │ J. Pharm. Pharmacol. │ 57,759-764 (共著)
26.	2003	Different contribution of CYP2C19 in the in vitro metabolism of three proton pump inhibitors. │ Biol. Pharm. Bull. │ 26,386-390 (共著)
27.	2003	Effects of carvedilol on MDR1-mediated multidrug resistance: comparison with verapamil. │ Cancer Sci. │ 94,81-86 (共著)
28.	2003	Effects of various storage conditions and alterations of antioxidant contents on chromatic aberration of hydroquinone ointment. │ Biol. Pharm. Bull. │ 26,120-122 (共著)
29.	2002	Interaction of digoxin with antihypertensive drugs via MDR1. │ Life Sci. │ 70,1491-1500 (共著)
30.	2002	MDR1-mediated interaction of digoxin with antiarrhythmic or antianginal drugs. │ Biol. Pharm. Bull. │ 25,1604-1607 (共著)
31.	2002	Simvastatin and lovastatin, but not pravastatin, interact with MDR1. │ J. Pharm. Pharmacol. │ 54,419-423 (共著)
32.	2001	Effect of serum triglyceride concentration on the fluctuation of whole blood concentration of cyclosporin A in patients. │ Biol. Pharm. Bull. │ 24,683-687 (共著)
33.	2001	Factors influencing the prediction of steady state concentrations of digoxin. │ Biol. Pharm. Bull. │ 24,403-408 (共著)
34.	2001	MDR1 genotype-related pharmacokinetics of digoxin after single oral administration in healthy Japanese subjects. │ Pharm. Res. │ 18,1400-1404 (共著)
35.	1999	Chemopreventive effect of dietary flavonoid morin on chemically induced rat tongue carcinogenesis. │ Int. J. Cancer. │ 83,381-386 (共著)
36.	1999	Modifying effects of a flavonoid morin on azoxymethane-induced large bowel tumorigenesis in rats. │ Carcinogenesis │ 20,1477-1484 (共著)
37.	1998	Chemoprevention of 4-nitroquinoline 1-oxide-induced oral carcinogenesis by citrus auraptene in rats. │ Carcinogenesis │ 19,425-431 (共著)
38.	1998	Citrus auraptene exerts dose-dependent chemopreventive activity in rat large bowel tumorigenesis: the inhibition correlates with suppression of cell proliferation and lipid peroxidation and with induction of phase II drug-metabolizing enzymes. │ Cancer Res. │ 58,2550-2556 (共著)
39.	1997	Chemoprevention of azoxymethane-induced rat colon carcinogenesis by a xanthine oxidase inhibitor, 1'-acetoxychavicol acetate. │ Jpn. J. Cancer. Res. │ 88,821-830 (共著)
40.	1997	Chemoprevention of azoxymethane-induced rat colon carcinogenesis by the naturally occurring flavonoids, diosmin and hesperidin. │ Carcinogenesis │ 18,957-965 (共著)
41.	1997	Citrus auraptene inhibits chemically induced colonic aberrant crypt foci in male F344 rats. │ Carcinogenesis │ 18,2155-2161 (共著)
42.	1997	Modulation of N-methyl-N-amylnitrosamine-induced rat oesophageal tumourigenesis by dietary feeding of diosmin and hesperidin, both alone and in combination. │ Carcinogenesis │ 18,761-769 (共著)
43.	1996	Involvement of two basic residues (Lys-17 and Arg-39) of mouse lung carbonyl reductase in NADP(H)-binding and fatty acid activation: site-directed mutagenesis and kinetic analyses. │ J. Biochem. │ 120,257-263 (共著)